Status:
COMPLETED
ImproveR International (BI-001-IM)
Lead Sponsor:
Nycomed
Conditions:
Thrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI)
Eligibility:
All Genders
18-75 years
Brief Summary
The objectives of this registry are to assess the use of the thrombin-specific anticoagulant bivalirudin during percutaneous coronary intervention (PCI) in a real life setting. In particular, data wil...
Eligibility Criteria
Inclusion
- \> 18 years, undergoing planned or urgent PCI with the intention to use bivalirudin as anticoagulant, written informed concent to entry of data information registry.
Exclusion
- None
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
End Date :
September 1 2007
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT00290849
Start Date
March 1 2005
End Date
September 1 2007
Last Update
May 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nycomed
Roskilde, Denmark, 4000